| Literature DB >> 32532783 |
Jennifer Jones1,2, Michael Hughes3,4, John Pauling5,6, Rachael Gooberman-Hill2,7, Andrew J Moore8.
Abstract
OBJECTIVES: Digital ulcers (DUs) are a common complication in systemic sclerosis (SSc). No existing studies have specifically reported on the qualitative patient experience of DU pain, and our current patient-reported outcome measure (PROM) does not capture the multifaceted painful experience of SSc-DU. Our aim was to examine the patient experience of SSc-DU pain.Entities:
Keywords: pain management; qualitative research; rheumatology
Year: 2020 PMID: 32532783 PMCID: PMC7295424 DOI: 10.1136/bmjopen-2020-037568
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Demographics and clinical phenotype of enrolled participants (adapted with permission from Hughes et al3)
| Demographics/clinical phenotype | Bath | Manchester | London (1) | London (2) | Overall |
| Number of participants, n | 8 | 7 | 6 | 8 | 29 |
| Mean age in years, (range) | 66.1 (44.0–87.6) | 61.6 (41.9–73.3) | 50.4 (33.7–67.7) | 59.5 (36.7–72.7) | 59.9 (33.7–87.6) |
| Sex (F:M), n | 7:1 | 7:0 | 3:3 | 3:5 | 20:9 |
| Disease subtype, n | |||||
| LcSSc | 8 | 6 | 2 | 4 | 20 |
| DcSSc | 0 | 1 | 4 | 4 | 9 |
| Mean RP duration in years (range) | 20.7 (5.1–54.3) | 17.9 (2.0–48.3) | 23.1 (2.7–59.7) | 13.6 (3.7–32.7) | 18.5 (2.0–59.7) |
| Mean disease duration* in years (range) | 14.3 (3.3–33.3) | 10.9 (1.7–23.8) | 13.9 (1.7–37.7) | 13.2 (4.7–31.7) | 12.8 (1.7–37.7) |
| Early vs established disease†, n | |||||
| Early | 0 | 1 | 1 | 0 | 2 |
| Established | 8 | 6 | 5 | 8 | 27 |
| History of DU, n | |||||
| 1 previous DU | 1 | 1 | 0 | 1 | 3 |
| 2–4 previous DU | 3 | 3 | 2 | 1 | 9 |
| ≥5 previous DU | 4 | 3 | 4 | 6 | 17 |
| Ethnicity, n | |||||
| White/Caucasian | 7 | 6 | 5 | 5 | 23 |
| Black British | 0 | 1 | 1 | 2 | 4 |
| Asian | 1 | 0 | 0 | 1 | 2 |
| Vasodilator medication used‡, n | |||||
| None | 1 | 2 | 1 | 2 | 6 |
| Calcium channel blocker | 5 | 2 | 1 | 2 | 10 |
| Phosphodiesterase type-5 inhibitor | 5 | 4 | 4 | 5 | 18 |
| Endothelin receptor antagonist | 3 | 2 | 2 | 2 | 9 |
*Since first non-Raynaud’s symptom.
†Early and established disease (defined as ≤3 and >3 years since first non-Raynaud’s phenomenon symptom, respectively).
‡Indication not specified and includes SSc-RP, SSc-DU, SSc-pulmonary artery hypertension and/or systemic hypertension/cardiovascular risk.
DcSSc, diffuse cutaneous systemic sclerosis; DU, digital ulcer; LcSSc, limited cutaneous systemic sclerosis55; RP, Raynaud’s phenomenon.
Figure 1Pain experience: narrative devices and descriptive tools.
Words to describe intensity and nature of digital ulcer pain
| ‘unbelievable’ | ‘agonising’ | ‘really hurt’ | ‘throb’ | ‘constant pain’ | ‘excruciating’ |
| ‘stabbing feeling’ | ‘absolutely horrible’ | ‘properly painful’ | ‘absolutely agony’ | ‘pulsating pain’ | ‘very painful’ |
| ‘unbearable’ | ‘severe’ | ‘stingy’ | ‘agony’ | ‘intense pain’ |